Fugitive Profile: Hadi Mo GHANDOUR
Summary of OCI Investigation:
GHANDOUR distributed mislabeled and unapproved new drugs, counterfeit human growth hormone and controlled drugs to other distributors throughout the United States. As part of the scheme, GHANDOUR sold 7,938 units of Tiratricol, a potentially life threatening drug producing heart attacks and strokes, in nine months. Further, GHANDOUR purchased insulin vials, graphics for the lot numbers and expiration dates, along with a labelling machine, and mislabeled the vials of the insulin as human growth hormone.
On 9 March 2004, GHANDOUR pleaded guilty to three counts in an indictment before a United States Magistrate Judge for the Western District of Texas. Following his plea, GHANDOUR was allowed to remain on bail until his sentencing date, which was scheduled in the United States District Court for 25 May 2004. The court allowed GHANDOUR to travel to California for his business and then to Florida to visit his family. He was to return to Austin, Texas, on 26 March 2004, and report to officers the following morning. GHANDOUR failed to report as directed and efforts to locate and/or contact him have been unsuccessful.